Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).

4 total trials none currently recruiting 4 completed early-phase tilt upper quartile by trial count

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium: 4 sponsored US clinical trials, none currently recruiting.

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Atypical Chronic Myeloid Leukemia, BCR-ABL Negative, with 1 trials.

Upper-quartile sponsor footprint

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

4 total, page 1 of 1

COMPLETED Phase 3

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

NCT00799461
COMPLETED Phase 1

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

NCT00438984
COMPLETED Phase 2

Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission

NCT00031655
COMPLETED Phase 1

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

NCT00002787

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1
Phase 3 1

Therapeutic Areas

Atypical Chronic Myeloid Leukemia, BCR-ABL Negative 1
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) 1
Blastic Phase Chronic Myelogenous Leukemia 1
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) 1
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) 1
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) 1
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities 1
Accelerated Phase Chronic Myelogenous Leukemia 1
Adult Acute Myeloid Leukemia in Remission 1
Adult Acute Lymphoblastic Leukemia in Remission 1

How the Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium early-phase archive is shaped

4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).

Phase mix: 1 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: Atypical Chronic Myeloid Leukemia, BCR-ABL Negative (1 trial), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium: archived-pipeline peers nationwide

Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium4D pharma60 Degrees PharmaceuticalsA2 BiotherapeuticsAbdul Latif Jameel Poverty Action Lab10xBio22nd Century Group23andMe3-C Institute for Social Development
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 4 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium page

4 registered trials is a research-attention snapshot, not an endorsement of Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium or any single study.

  • None of Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Atypical Chronic Myeloid Leukemia, BCR-ABL Negative is the condition Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atypical Chronic Myeloid Leukemia, BCR-ABL Negative trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium pipeline card: 4 registered trials from official public datasets.Report a data error.